Applicants will gain access to a specialized free-of-charge IP licensing intermediary service, designed to facilitate the complex process of licensing assets within the biopharma industry. By applying to this call, applicants will increase their chances of securing a successful licensing deal, as their assets will be showcased to companies with matching interests.
Successful applicants, i.e., those whose assets generate interest from potential licensing partners, will have the opportunity to receive support from LEAP-BIO during negotiations, including assistance with negotiating term-sheets.
LEAP-BIO will continuously collect and update the licensing interests from the big pharma and biotech companies. Therefore, to increase the likelihood of successful matches between early-stage assets and the specific licensing interests of leading biopharma players, all assets submitted to the call will be added to a database, which will be regularly evaluated as new licensing interests are collected.